Blockchain Registration Transaction Record

SS Innovations Q2 Revenue Soars 39% on SSi Mantra Demand

SS Innovations reports record Q2 revenue of $13.9M, up 39.4%, driven by SSi Mantra surgical robot installations. FDA clearance and CE marking expected by 2027.

This news matters because it highlights the rapid growth and market acceptance of SS Innovations' SSi Mantra surgical robotic system, which is poised to compete with established players in the surgical robotics industry. The company's financial performance and upcoming regulatory milestones indicate potential for broader adoption and market expansion, which could impact healthcare providers, investors, and patients by offering a more accessible and innovative robotic surgery option.